Moderna reported positive results from an early trial of a vaccine targeting H5 influenza viruses, showing a 44.5-fold increase in antibody levels in a preliminary trial of 300 healthy adults.
Founders
Stéphane Bancel
Company Description
Moderna Therapeutics is a biotechnology company that specializes in vaccines and drug development.